Specific members of the Eph family of receptors and ligands have been shown to participate in angiogenesis, neural network development and axonal targeting. During development of the embryonic vasculature, EphB4 receptors are expressed on endothelial cells on arterial structures, while the ephrin-B ligand is restricted in expression to endothelium of the developing arterial vasculature. This laboratory has defined roles for EphB1 and ephrin B1 interactions in assembly of renal capillary microvasculature and in development of the glomerular microcirculation. Recent evidence has coupled receptor activation with activation of alphavbeta3 integrin has an important participant in tumor angiogenesis. This proposal addressed three aims to define functions of Eph receptors and ephrin ligands in the dermal microvasculature: 1) identify and characterize dermal capillary expression of Eph receptors and ephrin ligands using recombinant ectodomain fusions us high affinity binding reagents, 2) evaluate the dermal capillary expression of specific ephrins and EphB receptors in capillary endothelial cells marked by expression of beta-galactosidase under control of the flk-1 promoter, in models of wound healing and in response to sponges impregnated with ephrin ectodomains, and 3) establish transgenic mouse lines over- expressing ephrinB1/Fc (secreted) and ephrin1 (wt, transmembrane form) under control of the K14 epidermal basal keratinocyte promoter. These studies promise to evaluate effects of local over-expression on vascular structures and wound healing, and to define functions of this important ligand receptor system in the dermal microvasculature.

Project Start
2000-05-01
Project End
2001-04-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
7
Fiscal Year
2000
Total Cost
$85,340
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Russell, Shirley B; Smith, Joan C; Huang, Minjun et al. (2015) Pleiotropic Effects of Immune Responses Explain Variation in the Prevalence of Fibroproliferative Diseases. PLoS Genet 11:e1005568
Velez Edwards, Digna R; Tsosie, Krystal S; Williams, Scott M et al. (2014) Admixture mapping identifies a locus at 15q21.2-22.3 associated with keloid formation in African Americans. Hum Genet 133:1513-23
Duncan, F Jason; Silva, Kathleen A; Johnson, Charles J et al. (2013) Endogenous retinoids in the pathogenesis of alopecia areata. J Invest Dermatol 133:334-43
Jandova, Jana; Shi, Mingjian; Norman, Kimberly G et al. (2012) Somatic alterations in mitochondrial DNA produce changes in cell growth and metabolism supporting a tumorigenic phenotype. Biochim Biophys Acta 1822:293-300
Takahashi, Keiko; Mernaugh, Raymond L; Friedman, David B et al. (2012) Thrombospondin-1 acts as a ligand for CD148 tyrosine phosphatase. Proc Natl Acad Sci U S A 109:1985-90
Jandova, Jana; Eshaghian, Alex; Shi, Mingjian et al. (2012) Identification of an mtDNA mutation hot spot in UV-induced mouse skin tumors producing altered cellular biochemistry. J Invest Dermatol 132:421-8
Sundberg, J P; Taylor, D; Lorch, G et al. (2011) Primary follicular dystrophy with scarring dermatitis in C57BL/6 mouse substrains resembles central centrifugal cicatricial alopecia in humans. Vet Pathol 48:513-24
Harries, M J; Sun, J; Paus, R et al. (2010) Management of alopecia areata. BMJ 341:c3671
Yang, Jinming; Splittgerber, Ryan; Yull, Fiona E et al. (2010) Conditional ablation of Ikkb inhibits melanoma tumor development in mice. J Clin Invest 120:2563-74
Russell, Shirley B; Russell, James D; Trupin, Kathryn M et al. (2010) Epigenetically altered wound healing in keloid fibroblasts. J Invest Dermatol 130:2489-96

Showing the most recent 10 out of 139 publications